參考文獻(xiàn)/References:
[1] 沈瑩姍,何曉銘,趙雄,等.關(guān)于“血瘀證是股骨頭壞死主要證候”的調(diào)查研究[J].中醫(yī)正骨,2022,34(4):25-29.
[2] 周明旺,劉一飛,吉星,等.基于“瘀去 -新生 -骨合”理論應(yīng)用活血化瘀法治療股骨頭壞死的思路探討[J].時(shí)珍國醫(yī)國藥,2020,31(12):2988-2990.
[3] 赫龍,高爽,李志剛,等.基于三大組學(xué)探討從“痰、虛、瘀”論治SANFH的可行性[J].時(shí)珍國醫(yī)國藥,2022,33(8):1947-1949.
[4] 黃建烽,何海軍.從酒傷理論論治酒精性股骨頭壞死[J].中醫(yī)正骨,2022,34(9):69-72.
[5] 李子榮.股骨頭壞死:早期診斷與個(gè)體化治療[J].中國矯形外科雜志,2013,21(19):1909-1911.
[6] 李子榮.股骨頭壞死成功保髖新理念[J].中醫(yī)正骨,2018,30(10):1-3.
[7] 楊博,邢濤,張應(yīng)拴,等.從伏邪理論論治激素性股骨頭壞死[J].中醫(yī)正骨,2023,35(2):54-57.
[8] LI Z,CHENG L,WANG K,et al.Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head—A first multicentre,randomised,double-blind,placebo-controlled clinical trial[J].J Orthop Translat,2018,12:36-44.
[9] 羅月中,李蕓,李勇,等.補(bǔ)腎健骨法預(yù)防腎病綜合征患者激素性股骨頭壞死臨床研究[J].中醫(yī)正骨,2011,23(1):3-6.
[10] 何偉.精確診斷前提下股骨頭壞死非手術(shù)治療實(shí)踐[J].臨床外科雜志,2017,25(8):580-582.
[11] 何偉.如何把握股骨頭壞死患者的保髖治療時(shí)機(jī)[J].中國骨與關(guān)節(jié)雜志,2016,5(2):82-86.
[12] WEI Q,HONG G,YUAN Y,et al.Huo Xue Tong Luo capsule,a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head:a prospective study[J].J OrthopTranslat,2019,18: 65-73.
[13] MIN B,SONG K,CHO C,et al.Untreated asymptomatic hips in patients with osteonecrosis of the femoral head[J].Clin Orthop Relat Res,2008,466(5):1087-1092.
[14] HE X,HE M,YANG P,et al.The therapeutic effect of Huo Xue Tong Luo capsules in Association Research Circulation Osseous(ARCO)stage II osteonecrosis of the femoral head:a clinical study with an average follow-up period of 7.95 years[J].Front Pharmacol,2021,12:773758.
[15] 蔡劍.整體觀指導(dǎo)下非創(chuàng)傷性股骨頭壞死“帶塌陷生存”的臨床及有限元研究[D].廣州:廣州中醫(yī)藥大學(xué),2018.
[16] 何偉.科學(xué)看待中醫(yī)藥治療非創(chuàng)傷性股骨頭壞死[J].中華關(guān)節(jié)外科雜志(電子版),2013,7(3):284-286.
[17] ZHAO D,ZHANG F,WANG B,et al.Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults(2019 version)[J].J Orthop Translat,2020,21:100-110.
[18] MONT M A,CHERIIAN J J,SIERRA R J,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?A ten-year update[J].J Bone Joint Surg Am,2015,97(19):1604-1627.
[19] 劉予豪,周馳,陳雷雷,等.基于股骨頭壞死圍塌陷期理論的保髖術(shù)式總結(jié)[J].中國修復(fù)重建外科雜志,2017,31(8):1010-1015.
[20] 李泰賢,沈丹青,薛志鵬,等.針刀療法改善股骨頭壞死關(guān)節(jié)功能的近期療效觀察[J].中國中醫(yī)骨傷科雜志,2018,26(4):24-28.
[21] 顏炎,李泰賢,傅繁譽(yù),等.針刀刺激肌筋膜疼痛觸發(fā)點(diǎn)治療股骨頭壞死的療效觀察及作用機(jī)制探討[J].中醫(yī)正骨,2020,32(11):62-65.
[22] 高在偉,韋偉,韋標(biāo)方.雙柏散治療非創(chuàng)傷性股骨頭壞死的早期觀察[J].中國矯形外科雜志,2020,28(21):2005-2007.
[23] MONT M A,ZYWIEEL M G,MARKER D R,et al.The natural history of untreated asymptomatic osteonecrosis of the femoral head:a systematic literature review[J].J Bone Joint Surg Am,2010,92(12):2165-2170.
[24] LIU L,ZHANG Q,SUN W,et al.Corticosteroid-induced osteonecrosis of the femoral head:detection,diagnosis,and treatment in earlier stages[J].Chin Med J(Engl),2017,130(21):2601-2607.
[25] 陳志偉,李泰賢,萬曉旭,等.股骨頭壞死誤診相關(guān)因素研究[J].中國骨傷,2017,30(11):1000-1003.
[26] 魏秋實(shí),何偉,張慶文,等.股骨頭壞死中醫(yī)證型分布規(guī)律的文獻(xiàn)研究和系統(tǒng)評價(jià)[J].中華關(guān)節(jié)外科雜志(電子版),2013,7(3):369-372.
[27] 李泰賢,陳志偉,王榮田,等.基于文獻(xiàn)計(jì)量學(xué)分析中醫(yī)藥治療股骨頭壞死的研究現(xiàn)狀[J].中國中醫(yī)骨傷科雜志,2017,25(4):41-46.
[28] 許珂,宇文星,宋夢歌,等.股骨頭壞死全髖關(guān)節(jié)置換術(shù)患者的人群特征與臨床特點(diǎn)分析[J].中醫(yī)正骨,2020,32(1):51-55.
[29] 中華中醫(yī)藥學(xué)會.股骨頭壞死中醫(yī)療效評價(jià)標(biāo)準(zhǔn)(2019年版)[J].中醫(yī)正骨,2019,31(6):3-6.
[30] 何海軍,陳衛(wèi)衡.將生存質(zhì)量引入中醫(yī)藥治療股骨頭壞死療效評價(jià)體系的思考[J].中國中醫(yī)骨傷科雜志,2009,17(4):62-63.
[31] TIAN G,ZHAO C,ZHANG X,et al.Evidence-based traditional Chinese medicine research:two decades of development,its impact,and breakthrough[J].J Evid Based Med,2021,14(1):65-74.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(11):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(11):20.
[11]黃澤青,李泰賢,高歡歡,等.深化股骨頭壞死證候生物學(xué)基礎(chǔ)研究的重要性探討[J].中醫(yī)正骨,2024,36(03):68.